Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03267940
Title Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Halozyme Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic of Arizona Phoenix Arizona 85054 United States Details
University of Arizona Tucson Arizona 85724 United States Details
City of Hope Duarte California 91010 United States Details
Scripps La Jolla California 92037 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California Irvine Division of Hematology-Oncology, Department of Medicine UC Irvine Health Orange California 92868 United States Details
UC Davis Sacramento California 95817 United States Details
UCLA - David Geffen School of Medicine Santa Monica California 90404 United States Details
The Oncology Institute of Hope and Innovation Whittier California 90603 United States Details
Yale Cancer Center New Haven Connecticut 06511 United States Details
Lombardi Cancer Center, Georgetown University Washington District of Columbia 20007 United States Details
Johns Hopkins Baltimore Maryland 21287 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Mount Sinai New York New York 10029 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
UT Health Cancer Center San Antonio Texas 78229 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Mason Seattle Washington 98101 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Froedtert Hospital And Medical College Milwaukee Wisconsin 53226 United States Details
Samsung Medical Center Seoul Gangnam-gu 06351 Korea, Republic of Details
Korea University Guro Hospital Seoul Guro-gu 08308 Korea, Republic of Details
Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do 13620 Korea, Republic of Details
Seoul National University Hospital Seoul Jongno-gu 03080 Korea, Republic of Details
The Catholic University of Korea Seoul St. Mary's Hospital Seoul Seocho-gu 06591 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul Seodaemun-Gu 03722 Korea, Republic of Details
Asan Medical Center Seoul Songpa-gu 05505 Korea, Republic of Details
Maharaj Nakorn Chiang Mai Hospital Chiang mai Muang 50200 Thailand Details
King Chulalongkorn Memorial Hospital Bangkok Patumwan 10330 Thailand Details
Prince of Songkla University Hat Yai Songkla 90110 Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field